Literature DB >> 16328410

Viable head and neck tumor spheroids stimulate in vitro autologous monocyte MCP-1 secretion through soluble substances and CD14/lectin-like receptors.

Carla Olsnes1, John-Helge Heimdal, Kenneth W Kross, Jan Olofsson, Hans Jørgen Aarstad.   

Abstract

Biopsies from carcinoma tissue and benign control mucosa from head and neck squamous cell carcinoma (HNSCC) patients were used to establish fragment (F)-spheroids in vitro. We have previously shown that autologous monocytes co-cultured with F-spheroids in vitro augment their secretion of monocyte chemotactic protein-1 (MCP-1). Presently, the aims of the present work were to study whether the metabolic activity, secreted products and/or specific receptor/ligand on the surface of the F-spheroids and monocytes are necessary for stimulation of the monocyte MCP-1 secretion upon F-spheroid co-culture. Actinomycin D (1 mug/ml for 24 h) pre-treatment of the F-spheroids abolished the monocyte MCP-1 co-culture response. Co-culture of monocytes and F-spheroids separated by a semi-permeable membrane showed a decreased, but still present, monocyte MCP-1 co-culture response. Conditioned medium from F-spheroids stimulated allogenous monocytes to secrete MCP-1. The addition of glucose or galactose, but not mannose, to co-cultures partially inhibited the monocyte MCP-1 co-culture response. The addition of anti-CD14 antibody diminished the MCP-1 co-culture response. In conclusion, the monocyte MCP-1 co-culture response is dependent on metabolically active spheroids, secreted stimuli, and is augmented by direct contact with F-spheroids, possibly via lectin-like receptors and the CD14 receptor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16328410     DOI: 10.1007/s00405-004-0902-1

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  44 in total

1.  Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells.

Authors:  M Nesbit; H Schaider; T H Miller; M Herlyn
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

Review 2.  Toll receptors, CD14, and macrophage activation and deactivation by LPS.

Authors:  Marina A Dobrovolskaia; Stefanie N Vogel
Journal:  Microbes Infect       Date:  2002-07       Impact factor: 2.700

Review 3.  Natural killer cells and tumor therapy.

Authors:  T L Whiteside; N L Vujanovic; R B Herberman
Journal:  Curr Top Microbiol Immunol       Date:  1998       Impact factor: 4.291

4.  Monocytes secrete interleukin-6 when co-cultured in vitro with benign or malignant autologous fragment spheroids from squamous cell carcinoma patients.

Authors:  J Heimdal; H J Aarstad; J Olofsson
Journal:  Scand J Immunol       Date:  2000-03       Impact factor: 3.487

5.  Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium.

Authors:  A Bøyum
Journal:  Scand J Immunol       Date:  1983-05       Impact factor: 3.487

6.  Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy.

Authors:  Bernard Burke; Ngai Tang; Kevin P Corke; Dean Tazzyman; Kurosh Ameri; Michael Wells; Claire E Lewis
Journal:  J Pathol       Date:  2002-02       Impact factor: 7.996

7.  Human CD14 mediates recognition and phagocytosis of apoptotic cells.

Authors:  A Devitt; O D Moffatt; C Raykundalia; J D Capra; D L Simmons; C D Gregory
Journal:  Nature       Date:  1998-04-02       Impact factor: 49.962

Review 8.  Galectins and cancer.

Authors:  André Danguy; Isabelle Camby; Robert Kiss
Journal:  Biochim Biophys Acta       Date:  2002-09-19

9.  Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes.

Authors:  D D Taub; P Proost; W J Murphy; M Anver; D L Longo; J van Damme; J J Oppenheim
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  In vitro T-lymphocyte function in head and neck cancer patients.

Authors:  J H Heimdal; H J Aarstad; A Aakvaag; J Olofsson
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 3.236

View more
  2 in total

1.  Evaluation of spheroid head and neck squamous cell carcinoma cell models in comparison to monolayer cultures.

Authors:  Lorenz Kadletz; Gregor Heiduschka; Julian Domayer; Rainer Schmid; Elisabeth Enzenhofer; Dietmar Thurnher
Journal:  Oncol Lett       Date:  2015-07-14       Impact factor: 2.967

2.  Stroma-Rich Co-Culture Multicellular Tumor Spheroids as a Tool for Photoactive Drugs Screening.

Authors:  Ilya Yakavets; Samuel Jenard; Aurelie Francois; Yulia Maklygina; Victor Loschenov; Henri-Pierre Lassalle; Gilles Dolivet; Lina Bezdetnaya
Journal:  J Clin Med       Date:  2019-10-15       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.